Derivative Suit Filed In Wake Of Record Pfizer Payout
The entire board of directors at Pfizer Inc. and certain executives have been smacked with a shareholder derivative lawsuit alleging they harmed the company by promoting prescription drugs for unapproved, off-label...To view the full article, register now.
Already a subscriber? Click here to view full article